Stock screener

INSM

Conviction 55HealthcareScan · Thu, Sep 24, 2026

INSMED Inc (INSM) closed at $121.65 (+2.80%) on Sep 24, 2026. Price is above its 50-day and below its 200-day moving average. RSI(14) 49, RS Rating 55, -42.5% from its 52-week high, -31.3% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

INSM$121.65+2.80%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
2
3
2
Vol MA14 2.2M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
INSMED IncPHARMACEUTICAL PREPARATIONSwww.insmed.com ↗
Price121.65
Change+2.80%
Gap+0.68%
Rel volume1.28×
Avg volume2.07M
Avg $ vol255.48M
SMA 20123.34
SMA 50119.03
SMA 200135.51
Price vs 50+2.20%
Price vs 200-10.23%
MA stackmixed
50/200 cross—
Supertrendup · 113.70
RSI (14)49
MACD hist-0.95
MACD cross—
Stoch %K / %D35 / 22
ADX (14)16
+DI / −DI17 / 25
RSI divergence—
MACD divergence—
ATR %4.05%
ADR %3.87%
52w high211.41
52w low91.88
From 52w high-42.46%
Above 52w low+32.40%
New 52w highNo
SqueezeOn · 11d
Bollinger width10.64%
%B0.37
Donchian pos34.83%
Donchian high130.83
Donchian low116.74
AVWAP (52w high)133.39
vs AVWAP high-8.80%
AVWAP (52w low)111.39
vs AVWAP low+9.21%
OBV trendFlat
Chaikin MF (20)0.02
Today vs 20d1.28×
Avg vol (14d)2.2M
Avg vol (20d)2.07M
Avg $ vol (20d)255.48M
Market cap26.57B
RS Rating55 / 99
RS 3m (vs SPY)+11.95%
RS 6m (vs SPY)-34.79%
RS line new highNo
Trend template3/8
Technical rank40.5
1 week-1.88%
1 month-1.81%
3 months+16.44%
6 months-17.98%
1 year-16.32%
YTD-31.32%
P/E-20.81
P/B35.07
P/S43.81
P/FCF-27.46
EPS-6.42
Div yield—
ROE-168.55%
ROA-60.72%
Debt/Eq1.01
Current3.72
EV/EBITDA-21.58
Gross margin18.51%
Net margin-210.54%
Rev growth66.73%
EPS growth-39.73%
Price target199.79
Target upside64.23%
Analyst ratingBuy
Institutional112.59%
Ent. value26.79B
Revenue425.49M
Net income-13.24M
Gross profit33.02M
Free cash flow-967.58M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out216.75M
Employees1.66K
ListedThu, Jun 1, 2000
Free float213.12M
Float %98.9%
Short interest11.44M
Days to cover6.9d
Short volume46.2%
Squeeze score44 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.52 vs −$0.69
Last surprise+24.6% beat
Setup gradeC
Conviction55 / 100
Pattern quality—
Tech rank40.5 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance134.40
Support106.79
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in INSM · 6 recent

All disclosures →
MemberSideAmount
Josh Gottheimer
Josh Gottheimer
house · D · NJ · traded 2026-06-10
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-09-22
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-08-08
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-07-07
Sell$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · D · NJ · traded 2025-06-16
Buy$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · D · NJ · traded 2025-04-09
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in INSM · open-market 3 sells

InsiderSideShares
Brennan David R
Director · Common Stock · 2026-09-09
Sell25K
SHAROKY MELVIN MD
Director · Common Stock · 2026-08-17
Sell5K
Adsett Roger
Chief Operating Officer · Common Stock · 2026-08-10
Exercise82.28K
Adsett Roger
Chief Operating Officer · Common Stock · 2026-08-10
Exercise76.6K
Adsett Roger
Chief Operating Officer · Common Stock · 2026-08-10
Exercise80.97K
Adsett Roger
Chief Operating Officer · Common Stock · 2026-08-10
Sell239.85K
Adsett Roger
Chief Operating Officer · Stock Option (right to buy) · 2026-08-10
Exercise82.28K
Adsett Roger
Chief Operating Officer · Stock Option (right to buy) · 2026-08-10
Exercise76.6K
Adsett Roger
Chief Operating Officer · Stock Option (right to buy) · 2026-08-10
Exercise80.97K
Flammer Martina M.D.
Chief Medical Officer · Stock Option (right to buy) · 2026-08-06
Exercise18.28K

SEC filings

EDGAR filings in INSM · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.